FDA Inspection 1088852 — Roechling Medical Lancaster, LLC
The FDA completed an inspection of Roechling Medical Lancaster, LLC on April 4, 2019 in Denver, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Denver, PA (United States)